E-Book | October 19, 2018

Blinding Of Investigational Medicinal Products (IMPs)

Source: Almac Group

Clinical Supplies are now much more varied in dosage format and require blinding expertise.

Blinding or masking is intended to limit the occurrence of conscious and unconscious bias in the conduct an interpretation of a clinical trial. Blinding benefits both the patient and the investigator and Drug Encapsulation is an effective blinding method.

For additional blinding methods and information on Inhaler blinding methods and a dosage forms consideration checklists, download this informative eBook.

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader